SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-19-118247
Filing Date
2019-04-25
Accepted
2019-04-25 09:09:03
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d674092d20fa.htm 20-F/A 158328
2 EX-4.25 d674092dex425.htm EX-4.25 270958
3 EX-4.26 d674092dex426.htm EX-4.26 281152
4 EX-12.1 d674092dex121.htm EX-12.1 3583
5 EX-12.2 d674092dex122.htm EX-12.2 3553
  Complete submission text file 0001193125-19-118247.txt   718591
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-36891 | Film No.: 19765657
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1